BioSpace News Archive

Genentech, a member of the Roche Group, announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration for Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions.

Secured the potential for up to $5 million in new funding ($1.5 million of which has been funded to date) and further secured a 9% royalty on future U.S. sales of SUBA®-Itraconazole for basal cell carcinoma nevus syndrome (BCCNS) through revised agreement with majority shareholder and licensor Mayne Pharma Ventures Pty Ltd. (Mayne Pharma) Secured exclusive option to license next-generation itraconazole analogues from University of Connecticut (UCONN) for potential pipeline expansion, a

Carrum Health, the Center of Excellence Cloud platform for self-insured employers, announced it has added Johns Hopkins Bayview Medical Center in Baltimore, Maryland as its newest Center of Excellence.

Abid Nazeer, MD, Chief Medical Officer of Symetria Health, unveils redefined treatment strategies in wake of deadly fentanyl emergence at Midwest Opioid Summit

Austin, Texas-based Company blends technology and peer support services to substantially reduce post addiction treatment relapse

Innovation in science and technology, new healthcare delivery models, data and analytics, and value-based pricing models expected to transform industry

Cedarville University’s Center for Pharmacy Innovation, the Ohio Pharmacists Foundation and the Ohio Pharmacy Association began a groundbreaking partnership to advance the expanding role of the pharmacist in American health care.

Accreditation Council for Medical Affairs and Dynamic Global Events are excited to announce a partnership to bring the first ever CE accredited live events for pharmaceutical industry professionals.

We’re at a critical point for the future of biosimilars in the U.S. Millions of American patients stand to benefit from increased utilization of these lower-cost, high-quality products.

CHAMPS Oncology Vice President Toni Hare, RHIT, CTR, announced she will retire on May 3, 2019 after more than 29 years of dedicated service to CHAMPS Oncology, her valued employees and clients across the country.